pioglitazone has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PPAR-γ protein and gene expression in COPD alveolar macrophages was compared with control smokers and never-smokers." | 1.40 | The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD. ( Fox, JC; Lea, S; Metcalfe, H; Plumb, J; Singh, D; Spicer, D; Woodman, P, 2014) |
| "Pioglitazone treatment of virally-infected smoke-exposed mice proved more efficacious than the steroid intervention." | 1.36 | Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. ( Bauer, CM; Botelho, FM; Brown, EG; Lambert, KN; Mossman, KL; Stämpfli, MR; Taylor, JD; Zavitz, CC, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhafez, AT | 1 |
| Gomaa, AMS | 1 |
| Ahmed, AM | 1 |
| Sayed, MM | 1 |
| Ahmed, MA | 1 |
| Lea, S | 1 |
| Plumb, J | 1 |
| Metcalfe, H | 1 |
| Spicer, D | 1 |
| Woodman, P | 1 |
| Fox, JC | 1 |
| Singh, D | 1 |
| Bauer, CM | 1 |
| Zavitz, CC | 1 |
| Botelho, FM | 1 |
| Lambert, KN | 1 |
| Brown, EG | 1 |
| Mossman, KL | 1 |
| Taylor, JD | 1 |
| Stämpfli, MR | 1 |
3 other studies available for pioglitazone and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Pioglitazone and/or irbesartan ameliorate COPD-induced endothelial dysfunction in side stream cigarette smoke-exposed mice model.
Topics: Animals; Antihypertensive Agents; Cigarette Smoking; Disease Models, Animal; Endothelium; Hypoglycem | 2021 |
The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Topics: Adrenal Cortex Hormones; Aged; Animals; Apoptosis; Chemokine CCL5; Dexamethasone; Female; Gene Expre | 2014 |
Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection.
Topics: Animals; Chemokines; Disease Models, Animal; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Hum | 2010 |